Eribulin mesylate in breast cancer

Author： Verdaguer Helena   Morilla Idoia   Urruticoechea Ander  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.9, Iss.6, 2013-11, pp. : 517-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 584-589

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination Chemotherapy of Mitomycin C and Methotrexate Was Effective on Metastatic Breast Cancer Resistant to Eribulin, Vinorelbine, and Bevacizumab after Anthracycline, Taxane, and Capecitabine

By  

Case Reports in Oncology, Vol. 9, Iss. 2, 2016-08 ,pp. : 422-426

Karger

Access to resources Recommend Favorite

BREAST CANCER

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 7, Iss. 10, 1959-10 ,pp. : 800-821

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer statistics: Breast cancer in situ

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 6, 2015-11 ,pp. : 481-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Wilms tumor and breast cancer

By  

CANCER, Vol. 121, Iss. 12, 2015-06 ,pp. : 2099-2099

John Wiley & Sons Inc

Access to resources Recommend Favorite